T. Rowe Price Health Sciences I THISX
99.94 USD +0.06 (+0.06%)
At closeNov 4, 2026, 8:07 AM EST
Day range unavailable
75.40 52-week range 101.13
- YTD
- +19.36%
- 1 year
- +14.36%
- Market cap
- 12.24B
- EPS (ttm)
- 2.98
- P/E ratio
- 33.51
- YTD return
- +19.36%
- 1-year return
- +14.36%
- Previous close
- 99.88
- 52-week range
- 75.40 – 101.13
2Y +3.26 (+3.37%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 95.78
- 200-day average
- 87.00
About T. Rowe Price Health Sciences I
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on THISX — it syncs with the Stock Master app.